Elevated plasma levels of F2(α) isoprostane in cystic fibrosis

Lipids

Volumn 34, Issue 6, 1999, Pages 551-556

  Collins, Clare E ^a,e   Quaggiotto, Paul ^b   Wood, Lisa ^b   O'Loughlin, Edward V ^c   Henry, Richard L ^d   Garg, Manohar L ^b  

^a JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e Comm Health Services and Nursing ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; ISOPROSTANE; PROSTAGLANDIN F2 ALPHA; RETINOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; INFLAMMATION; OXIDATIVE STRESS;

ADOLESCENT; ADULT; AGED; BETA CAROTENE; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DINOPROST; ERYTHROCYTE MEMBRANE; F2-ISOPROSTANES; FATTY ACIDS; HUMANS; MIDDLE AGED; VITAMIN A; VITAMIN E;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0032970268     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-999-0397-1     Document Type: Article

References (37)

1. 1-Proteinase Inhibitor Complex Levels Decrease in Plasma of Cystic Fibrosis Patients During Long-Term Oral β-Carotene Supplementation, Pediatr. Res. 40, 130-134.
2. Portal, B.C., Richard, M.J., Faure, H.S., Hadjian, A.J., and Favier, A.E. (1995) Altered Antioxidant Status and Increased Lipid Peroxidation in Children with Cystic Fibrosis, Am. J. Clin. Nutr. 61, 843-847.
3. Doring, G., Bellon, G., and Knight, R. (1995) Immunology of Cystic Fibrosis, in Cystic Fibrosis (Hodson, M.E., and Geddes, D.M., eds.) pp. 99-129, Chapman & Hall Medical, London.
4. Morrow, J.D., and Roberts, L.J., II (1996) The Isoprostanes. Current Knowledge and Directions for Future Research, Biochem. Pharmacol. 51, 1-9.
5. Lepage, G., Champagne, J., Ronco, N., Lamarre, A., Osberg, I., Sokol, R.J., and Roy, C.C. (1996) Supplementation with Carotenoids Corrects Increased Lipid Peroxidation in Children with Cystic Fibrosis, Am. J. Clin. Nutr. 64, 87-93.
6. Wilke, B.C., Vidailhet, M., Guillemin, C., Ducros, V., Arnaud, J., Richard, M.J., and Favier, A. (1990) Selenium Status and Antioxidant Injury in Cystic Fibrosis Children, Acta Univ. Carol. [Med.] 36, 81-83.
7. Richard, M.J., Aguilaniu, B., Arnaud, J., Gout, J.P., and Favier, A. (1990) Selenium and Oxidant Injury in Patients with Cystic Fibrosis, in Antioxidant in Therapy and Preventive Medicine, pp. 175-178, Plenum Press, New York.
8. Bilton, D., Maddison, J., Webb, A.K., Seabra, L., Jones, M., and Braganza, J.M. (1991) Cystic Fibrosis, Breath Pentane, and Lipid Peroxidation, Lancet 337, 1420.
9. Lepage, G., Frank Kneepkens, C.M., and Roy, C.C. (1993) Peroxisomal Dysfunction Associated with Essential Fatty Acid Deficiency, Med. Sci. 9, 571-576.
10. van der Vliet, A., Eiserich, J.P., Marelich, G.P., Halliwell, B., and Cross, C.E. (1997) Oxidative Stress in Cystic Fibrosis: Does It Occur and Does It Matter? Adv. Pharmacol. 38, 491-513.
11. Marelich, G.P., and Cross, C.E. (1996) Cystic Fibrosis in Adults: From Researcher to Practitioner, Acta Paediatr. 84, 1132-1136.
12. Gutteridge, J., and Halliwell, B. (1990) The Measurement and Mechanism of Lipid Peroxidation in Biological Systems, TIBS 15, 129-135.
13. Halliwell, B., and Grootveld, M. (1997) The Measurement of Free Radical Reactions in Humans. Some Thoughts for Future Experimentation, FEB Lett. 213, 9-14.
14. Cailleux, A., and Allain, P. (1993) Is Pentane a Normal Constituent of Human Breath? Free Radical Res. Commun. 18, 323-327.
15. 2α Induces Airflow Obstruction and Airway Plasma Exudation in vivo, Am. J. Respir. Crit. Care Med. 155, 436-441.
16. Shwachman, H,. and Kulczycki, L.L. (1958) Long-Term Study of One Hundred Five Patients with Cystic Fibrosis: Studies Made over a 5-to 14-Year Period, Am. J. Dis. Child 96, 6-15.
17. Cameron, N. (1978) Human Growth, Volume 2, Plenum Press, New York.
18. Pierce, R., and Johns, D.P. (1995) Spirometry, Melbourne, National Asthma Campaign Ltd.
19. Tomoda, A., Kodaira, K., Taketo, A., Tanimoto, K., and Yoneyama, Y. (1984) Isolation of Human Erythrocyte Membranes in Glucose Solution, Anal. Biochem. 140, 386-390.
20. Brown, A., Pang, E., and Roberts, D. (1991) Persistent Changes in the Fatty Acid Composition of Erythrocyte Membranes After Moderate Intake of n-3 Polyunsaturated Fatty Acids: Study Design Implications, Am. J. Clin. Nutr. 54, 668-673.
21. Lepage, G., and Roy, C.C. (1986) Direct Transesterification of All Classes of Lipid in a One-Step Reaction, J. Lipid Res. 27, 114-120.
22. Garg, M., and Blake, R. (1997) Cholesterol Dynamics in Rats Fed Diets Containing Either Canola Oil or Sunflower Oil, Nutr. Res. 17, 485-492.
23. Collins, C.E., O'Loughlin, E.V., and Henry, R.L. (1997) Fat Gram Target to Achieve High Energy Intake in Cystic Fibrosis, J. Paediatr. Child Health 33, 142-147.
24. Homnick, D.N., Cox, J.H., DeLoof, M.J., and Ringer, T.V. (1993) Carotenoid Levels in Normal Children and in Children with Cystic Fibrosis, J. Pediatr. 122, 703-707.
25. Winklhofer-Roob, B.M., Van't Hof, M.A., and Shmerling, D.H. (1995) Response of Cystic Fibrosis Patients to Oral β-Carotene Supplementation. A 16-Month Follow-up Study, Acta Paediatr. 84, 1132-1136.
26. Awad, J.A., Roberts L.J., II, Burk, R.F., and Morrow, J.D. (1996) Isoprostanes - Prostaglandin-Like Compounds Formed in vivo Independently of Cyclooxygenase, Gastroenterol. Clinics North America 25, 409-427.
27. Morrow, J.D., and Roberts, L.J. (1997) The Isoprostanes: Unique Bioactive Products of Lipid Peroxidation, Prog. Lipid Res. 36, 1-21.
28. Nanji, A.A., Khwaja, S., Tahan, S.R., and Sadrzadeh, S. (1994) Plasma Levels of a Novel Noncyclooxygenase-Derived Prostanoid (8-isoprostane) Correlate with Severity of Liver Injury in Experimental Alcoholic Liver Disease, J. Pharmacol. Exp. Ther. 269, 1280-1285.
29. 2α, in Pulmonary Oxygen Toxicity, J. Appl. Physiol. 77, 2912-2917.
30. 2-Isoprostane, on Endothelin-1 Release, J. Cardiovasc. Pharmacol. 26, S51-S52.
31. 2-Isoprostane in Vascular Smooth Muscle Cells by Elevated Glucose and Growth Factors, Am. J. Physiol. 271, H159-H165.
32. Christophe, A., and Robberecht, E. (1996) Current Knowledge on Fatty Acids in Cystic Fibrosis, Prostaglandins Leukotrienes Essent. Fatty Acids 55, 129-138.
33. Parsons, H.G., O'Loughlin, E.V., Forbes, D., Cooper, D., and Gall, D.G. (1988) Supplemental Calories Improve Essential Fatty Acid Deficiency in Cystic Fibrosis Patients, Pediatr. Res. 24, 353-356.
34. Mischler, E.H., Parrell, S.W., Farrell, P.M., Raynor, W.J., and Lernen, R.J. (1986) Correction of Linoleic Acid Deficiency in Cystic Fibrosis, Pediatr. Res. 20, 36-41.
35. Hubbard, V.S., and Dunn, G.D. (1980) Fatty Acid Composition of Erythrocyte Phospholipids from Patients with Cystic Fibrosis, Clin. Chim. Acta 102, 115-118.
36. Biggemann, B., Laryea, M.D., Schuster, A., Griese, M., Reinhardt, D., and Bremer, H.J. (1988) Status of Plasma and Erythrocyte Fatty Acids and Vitamins A and E in Young Children with Cystic Fibrosis, Scand. J. Gastroenterol. 23, 135-141.
37. Strandvik, B., Bronnegard, M., Gilliam, H., and Carlstedt-Duke, J. (1988) Relation Between Defective Regulation of Arachidonic Acid Release and Symptoms in Cystic Fibrosis, Scand. J. Gastroenterol. 23, 1-4.